Wickes Group PLC Transaction in Own Shares

RNS Number : 2216E

Wickes Group PLC

16 September 2024

 

16^th September 2024

Wickes Group plc

("Wickes" or the "Company")

Transaction in Own Shares

 

Wickes Group plc ("Wickes" or the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each through Peel Hunt LLP ("Peel Hunt").

Ordinary Shares

Date of purchase:	13th September 2024
Number of ordinary shares purchased:	53,123
Lowest price per share (pence):	173.4
Highest price per share (pence):	175.4
Weighted average price per day (pence):	174.6688

 

The Company intends to cancel the purchased shares.

 

Including the above purchases, Wickes has purchased a total of 17,571,699 ordinary shares since the commencement of the buyback programme. 

 

Following the purchase and cancellation of these shares, the Company's issued share capital will consist of 242,066,299. The Company does not hold any shares in Treasury.

Once the shares are cancelled, the total number of voting rights in Wickes will therefore be 242,066,299. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. 

The table below contains detailed information about the purchases made as part of the buyback programme.

 

Aggregate information:

Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
XLON	174.6688	53,123	173.4000	175.4000

 

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company as part of the Programme is detailed below:

 

Date and time of each trade	Number of shares purchased	Price (pence per share)	Trading Venue	Transaction Reference Number
13th September 2024 08:46:38	495	173.6	XLON	00166480806TRLO0
13th September 2024 08:46:38	992	173.6	XLON	00166480805TRLO0
13th September 2024 08:46:39	223	173.4	XLON	00166480808TRLO0
13th September 2024 08:46:39	1543	173.4	XLON	00166480809TRLO0
13th September 2024 09:02:11	1646	174	XLON	00166481806TRLO0
13th September 2024 14:34:47	1583	174.4	XLON	00166502789TRLO0
13th September 2024 14:35:36	1696	174.4	XLON	00166502935TRLO0
13th September 2024 14:35:39	1750	174.2	XLON	00166502943TRLO0
13th September 2024 14:39:11	1427	173.8	XLON	00166503595TRLO0
13th September 2024 14:39:11	218	173.8	XLON	00166503596TRLO0
13th September 2024 14:40:51	1641	173.8	XLON	00166503813TRLO0
13th September 2024 14:45:03	405	173.6	XLON	00166504357TRLO0
13th September 2024 14:45:03	711	173.6	XLON	00166504358TRLO0
13th September 2024 14:45:03	549	173.6	XLON	00166504359TRLO0
13th September 2024 14:47:16	25	174	XLON	00166504591TRLO0
13th September 2024 15:11:51	13	174	XLON	00166507768TRLO0
13th September 2024 15:57:08	30083	174.9	XLON	00166514177TRLO0
13th September 2024 16:03:24	8000	175.2	XLON	00166514934TRLO0
13th September 2024 16:12:28	122	175.4	XLON	00166516215TRLO0
13th September 2024 16:15:44	1	175.4	XLON	00166516665TRLO0

 

 

For further information please contact:

 

 

Holly Grainger

Director of Investor Relations

07341 680426

[e-mail]

 

Lucy Legh, Will Smith
Headland - PR Adviser to the Company
[phone]
[e-mail]

 

LEI: 213800IEX9ZXJRAOL133

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSUOVWRSNUKAAR